Please login to the form below

Not currently logged in
Email:
Password:

Cystic Fibrosis Buyers' Club

This page shows the latest Cystic Fibrosis Buyers' Club news and features for those working in and with pharma, biotech and healthcare.

BuyersClub wants government support on Orkambi imports

Buyers’ Club wants government support on Orkambi imports

The Cystic Fibrosis Buyers’ Club has asked health secretary Matt Hancock to help patients circumvent Vertex and find alternative ways to gain access to Orkambi – including the import of generic versions ... compulsory licensing) crown use licence,

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    Dialogue with pharma? No thanks. As with the UK’s Cystic Fibrosis Buyers’ Club advocates, T1International doesn’t see dialogue with pharma as being worthwhile – after years of frustration and debates

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis BuyersClub

    to source what could also be life- saving drugs: the Cystic Fibrosis Buyers’ Club. ... Dairmaid McDonald and the Just Treatment team are supporting the Cystic Fibrosis Buyers’ Club to make the goal a reality, and have approached the task with

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....